Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials

BACKGROUND: We characterized the efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in a broad population of pediatric/adolescent/adult/elderly females living with HIV (FWH). SETTING: Integrated analysis. METHODS: Available data from 5 trials were integrated. Week 48 vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Orkin, Chloe, Ajana, Faiza, Kityo, Cissy, Koenig, Ellen, Natukunda, Eva, Gandhi-Patel, Bhumi, Wang, Hui, Liu, Yapei, Wei, Xuelian, White, Kirsten, Makadzange, Tariro, Pikora, Cheryl, McNicholl, Ian, Collins, Sean E., Brainard, Diana, Chuck, Susan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547745/
https://www.ncbi.nlm.nih.gov/pubmed/34506342
http://dx.doi.org/10.1097/QAI.0000000000002789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547745/
https://www.ncbi.nlm.nih.gov/pubmed/34506342
http://dx.doi.org/10.1097/QAI.0000000000002789

Ejemplares similares